Table 5: Medical therapy of 58 pediatric patients with ulcerative colitis at the time of diagnosis and during the follow up course.
| Medical therapy | n (%) |
|---|---|
| Prednisolone | 17 (77.3) |
| Mesalazine | 13 (59.1) |
| Pentasa | 11 (50) |
| Asacol | 4.0 (18.2) |
| Azathioprine | 11 (50) |
| Folic acid | 10 (45.5) |
| Iron supplementation | 9.0 (40.9) |
| Omeprazole | 8.0 (36.4) |
| Multivitamins | 7.0 (31.8) |
| Adalimumab | 7.0 (31.8) |
| Calcium supplementation | 6.0 (27.3) |
| Infliximab infusion | 2.0 (9.1) |
| ADEK* supplementation | 4.0 (18.2) |
| Ursodeoxycholic acid 4.0 (18.2) | 4.0 (18.2) |
| Vitamin D supplementation | 3.0 (9.1) |
| Cimitidine | 1.0 (4.5) |
*Fat soluble vitamins A, D, E, K.